Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Genitourinary 1

Conditions

Thrombocytosis 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Penile Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Blast Crisis 1Anemia 1

Interventions

pembrolizumab 6Nivolumab 5atezolizumab 3Paclitaxel 3regorafenib 1osimertinib 1fludarabine 1dacomitinib 1cobimetinib 1avelumab 1aldesleukin 1aflibercept 1Vorinostat 1Therapeutics 1Taxes 1RXDX-106 1Proton Pump Inhibitors 1Pemetrexed 1NEO212 1Ipilimumab 1Interleukin-2 1In Situ Hybridization, Fluorescence 1Immunotherapy 1IRX 2 1IFL protocol 1Hydrocortisone 1Cyclophosphamide 1Cisplatin 1Carboxylesterase 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × dacomitinib × Genitourinary × Clear all
NCT01728233 2021-05-14

HER-Uro01

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed
32 enrolled
Genitourinary

Carcinoma, Squamous Cell, Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡